Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Ali Omrani

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Current Medicinal Chemistry|December 15, 2023
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled TrialsBehrooz Heydari, Adeleh Sahebnasagh, Mohammad Ali Omrani, et al.
British Journal of Clinical Pharmacology|December 5, 2025
Machine learning methods for predicting adverse drug events: A systematic reviewNiaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2026
Fluoroquinolones and the risk of panic attacks: a systematic review and disproportionality analysis using individual case safety reports from the FDA Adverse Event Reporting System (FAERS) databaseKeeirah Hiertika Raguram, Manroop Sidhu, Mohammad Ali Omrani, et al.
Seminars in Dialysis|May 13, 2026
Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving DialysisFlory T Muanda, Peter G Blake, Matthew A Weir, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Current Medicinal Chemistry|December 15, 2023
Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled TrialsBehrooz Heydari, Adeleh Sahebnasagh, Mohammad Ali Omrani, et al.
British Journal of Clinical Pharmacology|December 5, 2025
Machine learning methods for predicting adverse drug events: A systematic reviewNiaz Chalabianloo, Fatemeh Ahmadi, Mohammad Ali Omrani, et al.
The Journal of Antimicrobial Chemotherapy|March 6, 2026
Fluoroquinolones and the risk of panic attacks: a systematic review and disproportionality analysis using individual case safety reports from the FDA Adverse Event Reporting System (FAERS) databaseKeeirah Hiertika Raguram, Manroop Sidhu, Mohammad Ali Omrani, et al.
Seminars in Dialysis|May 13, 2026
Risk of Serious Adverse Events and Death With Low-Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving DialysisFlory T Muanda, Peter G Blake, Matthew A Weir, et al.
Pageof 2